brl 42359 has been researched along with sulindac in 1 studies
| Studies (brl 42359) | Trials (brl 42359) | Recent Studies (post-2010) (brl 42359) | Studies (sulindac) | Trials (sulindac) | Recent Studies (post-2010) (sulindac) |
|---|---|---|---|---|---|
| 11 | 1 | 3 | 1,462 | 202 | 305 |
| Protein | Taxonomy | brl 42359 (IC50) | sulindac (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2.69 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.69 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 0.293 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, T; Horiguchi, A; Kitamura, S; Kotake, Y; Ohshita, H; Ohta, S; Sanoh, S; Sugihara, K; Tateno, C; Tayama, Y | 1 |
1 other study(ies) available for brl 42359 and sulindac
| Article | Year |
|---|---|
Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
Topics: Animals; Cells, Cultured; Child, Preschool; Chimera; Cytochrome P-450 Enzyme System; Drug Evaluation, Preclinical; Drugs, Investigational; Female; Half-Life; Hepatocytes; Humans; Immunomagnetic Separation; Liver; Male; Metabolic Clearance Rate; Mice; Mice, SCID; Recombinant Proteins; Species Specificity; Urokinase-Type Plasminogen Activator | 2012 |